Product Information
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) is a generic product labeled by NorthStar Rx LLC, priced at $0.6505 per EA under NDC 16714010001. Its NADAC has been published 260 times since Jul 7, 2021.
Strength
5 mg/1
Manufacturer
NorthStar Rx LLCNDC
16714010001
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
TACROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA206662On Market Since
3/31/2021
Pharmacological Classes
Price Statistics
The NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has been published 260 times since Jul 7, 2021, and over the history we have for it it has declined 75.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6505 per EA |
|---|---|
| All-time high | $2.6796 (Jul 14, 2021) |
| All-time low | $0.6505 (Jun 17, 2026) |
| 52-week high | $0.9577 |
| 52-week low | $0.6505 |
| Median price | $1.2552 |
| Average price | $1.3005 |
| Largest weekly change | -47.1% (Jul 21, 2021) |
| Weeks tracked | 260 |
| Tracking since | Jul 7, 2021 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
The current National Average Drug Acquisition Cost (NADAC) for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), manufactured by NorthStar Rx LLC, is $0.6505 per EA (NDC 16714010001), effective Jun 24, 2026.
How has the price of TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) changed over time?
Over the history we have for it, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has declined 75.7%. It has been tracked across 260 weekly CMS publications since Jul 7, 2021.
What are the highest and lowest recorded NADAC prices for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
Since Jul 7, 2021, the NADAC for TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) has ranged from a low of $0.6505 (Jun 17, 2026) to a high of $2.6796 (Jul 14, 2021), with a median of $1.2552 per EA.
Are there cheaper alternatives to TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE), but none are currently priced below it.
Who manufactures TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE)?
TACROLIMUS 5 MG CAPSULE (IMMEDIATE RELEASE) (NDC 16714010001) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification